Drugs and the skin: A concise review of cutaneous adverse drug reactions.
Del Pozzo-Magaña BR, Liy-Wong C.
Br J Clin Pharmacol. 2024 Aug;90(8):1838-1855. doi: 10.1111/bcp.15490. Epub 2022 Aug 29.
Fluconazole-induced drug rash with eosinophilia and systemic symptoms syndrome: a case report.
Kim S, Chen K, Stull W.
J Med Case Rep. 2025 May 29;19(1):257. doi: 10.1186/s13256-025-05321-z.
Drug-induced urticaria.
Tan EK, Grattan CE.
Expert Opin Drug Saf. 2004 Sep;3(5):471-84. doi: 10.1517/14740338.3.5.471.
Drug hypersensitivity in drug-resistant tuberculosis.
Katran ZY, Bulut İ, Babalık A, Keren M, Tepetam FM, Mersin SS, Örçen C, Yakut T, Yavuz D.
World Allergy Organ J. 2023 May 20;16(5):100778. doi: 10.1016/j.waojou.2023.100778. eCollection 2023 May.
Fixed drug eruption and anaphylaxis induced concurrently by erdosteine: a case report.
Sim DW, Yu JE, Koh YI.
Allergy Asthma Clin Immunol. 2021 Feb 5;17(1):15. doi: 10.1186/s13223-021-00517-6.
Drug-induced skin disease.
Kaplan AP.
J Allergy Clin Immunol. 1984 Oct;74(4 Pt 2):573-9. doi: 10.1016/0091-6749(84)90109-x.
Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists: A FAERS Database Analysis From 2018-2024.
Fat MN, Johnson HC, Farberg AS.
J Drugs Dermatol. 2026 Jan 1;25(1):11-16. doi: 10.36849/JDD.9448.
Mechanisms of drug eruptions: Part I.
Breathnach SM.
Australas J Dermatol. 1995 Aug;36(3):121-7. doi: 10.1111/j.1440-0960.1995.tb00953.x.
Serum Sickness-Like Reactions in Children-Is Lifelong Avoidance Indicated?
Norton AE, Risma K, Ben-Shoshan M.
J Allergy Clin Immunol Pract. 2025 May;13(5):969-977. doi: 10.1016/j.jaip.2025.01.041. Epub 2025 Feb 18.
Cutaneous effects of antihypertensive drugs.
Baccino D, Merlo G, Cozzani E, Rosa GM, Tini G, Burlando M, Parodi A.
G Ital Dermatol Venereol. 2020 Apr;155(2):202-211. doi: 10.23736/S0392-0488.19.06360-0. Epub 2019 Jun 12.
